awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42417359-556A5E2B-811F-41A1-9F06-F4243E7DF3F3
Q42417359-556A5E2B-811F-41A1-9F06-F4243E7DF3F3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42417359-556A5E2B-811F-41A1-9F06-F4243E7DF3F3
The changing landscape of treatment options for metastatic castrate-resistant prostate cancer: challenges and solutions for physicians and patients.
P2860
Q42417359-556A5E2B-811F-41A1-9F06-F4243E7DF3F3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42417359-556A5E2B-811F-41A1-9F06-F4243E7DF3F3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
013498473cb054669e6065d6fa5c728a6d1fceaa
P2860
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial